• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Good early data for Lumicell’s tumor-detecting system

Good early data for Lumicell’s tumor-detecting system

January 8, 2016 By Fink Densford

Lumicell

An early trial of Lumicell’s surgical imaging agent returned promising results, according to findings published Wednesday in Science Translational Medicine.

Lumicell’s surgical imaging system is made up of a hand-held single-cell detection imaging device and a cancer-specific molecular imaging agent, the company said. The technology is designed to be optimized for specific cancer-types and surgical procedures.

Early data from a trial of the system in 15 patients undergoing surgery for soft-tissue sarcoma or breast cancer indicated that the cancer-identifying agent was able to distinguish cancerous tissue in the patients without adverse effects.

“At the time of surgery, a pathologist can examine the tissue for cancer cells at the edge of the tumor using a microscope, but because of the size of cancer it’s impossible to review the entire surface during surgery. The goal is to give surgeons a practical and quick technology that allows them to scan the tumor bed during surgery to look for any residual fluorescence,” study senior author Dr. David Kirsch of the Duke University School of Medicine said in a press release.

A feasibility study of the system at Massachusetts General Hospital is evaluating the safety and efficacy of the system in a prospective trial of 50 women with breast cancer.

Lumicell won FDA approval to launch the feasibility study of its intraoperative imaging system for patients with esophageal, colorectal and pancreatic cancers. The study is supported by a grant from the National Cancer Institute’s Spore program.

“This pathologic technique to determine whether tumor remains in the patient is the best system we have currently, and has been in use for decades, but it’s not as accurate as we would like. If this technology is successful in subsequent trials, it would significantly change our treatment of sarcoma. If we can increase the cases where 100% of the tumor is removed, we could prevent subsequent operations and potentially cancer recurrence. Knowing where there is residual disease can also guide radiation therapy, or even reduce how much radiation a patient will receive,” senior study author Dr. Brian Brigman of Duke University School of Medicine said in prepared remarks.

Filed Under: Clinical Trials, Imaging, Oncology Tagged With: Lumicell

In case you missed it

  • DTW Podcast: Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey
  • EMA begins investigation of J&J COVID-19 vaccine’s blood clotting potential
  • Johnson & Johnson COVID-19 vaccine shipments plunge
  • Medtronic stent graft recall is serious
  • Olympus opens new U.S. medical business HQ in Massachusetts
  • Crown Aesthetics wins FDA clearance for wrinkle treatment device
  • FDA clears Activ Surgical hardware for enhanced surgical visualization
  • FDA tells hospitals: Stop reusing disposable masks
  • Outset Medical to raise nearly $366M from primary, upsized offerings
  • Are Black patients not getting LVADs as quickly as white patients?
  • St. Jude Medical founder and his Medical 21 raise $3M
  • Google, Varian partner on AI to boost cancer radiation therapy
  • How can medtech companies use more patient input to improve clinical trials?
  • FDA advisory committee positive about TransMedics’ OCS Heart system
  • Hologic to acquire Mobigiag in $795M deal
  • Dräger acquires majority share of Stimit and its tech to help people breathe
  • Sandia Labs seeks partners to make reusable masks

RSS From Medical Design & Outsourcing

  • Resonetics to expand manufacturing in Costa Rica
    Resonetics announced today it has leased new manufacturing space in Costa Rica to more than double its production there. The space, in a building near its current site in the Coyol Free Zone business park in Alajuela, will be expanded and reconfigured to create a 45,000 ft² production site. The move comes after the company… […]
  • Are Black patients not getting LVADs as quickly as white patients?
    Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure. According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest… […]
  • Viant expands factory in Costa Rica
    Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company said it invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. Begun in fall 2020, the expansion adds 14,000 ft² of ISO Class 8 cleanroom… […]
  • St. Jude Medical founder and his Medical 21 raise $3M
    Raising money for a startup company during a pandemic is no cakewalk, according to Manny Villafaña. But he did it. Medical 21, the latest venture for the founder of St. Jude Medical, has raised another $3 million in an equity offering, according to an SEC filing. The most recent round brings the Minneapolis-based startup’s total funding… […]
  • How can patient input improve clinical trials?
    The Medical Device Innovation Consortium (MDIC) has laid out some recommendations for improving medical device clinical trials with increased patient input. Having observed that clinical trial sponsors seldom refer to patient input — something the FDA issued guidance for in September 2019 — MDIC offered its view on increasing and using patient input to improve… […]
  • Orchid names new CFO
    Orchid Orthopedic Solutions (Holt, Mich.) announced this week that Matt Tharp has joined the company as chief financial officer. Tharp comes to Orchid from Ammega, where he held the role of CFO – Americas. He has more than 20 years of experience in supply chain, operations and finance and has held leadership roles at Midwest… […]
  • ICS establishes dedicated medical device practice
    Integrated Computer Solutions (ICS) is establishing a dedicated medical device practice amid increased demand for complex medtech. ICS said its work in the medical and life sciences markets has nearly doubled year-over-year as connected technologies drive innovation and transform healthcare. “There has been extraordinary innovation and growth in the medtech sector in recent years which… […]
  • SMC is expanding its Costa Rica facility
    SMC (Somerset, Wis.) recently announced that it will double the size of its Alajuela, Costa Rica facility to 120,000 ft2 this year. The additional space will enable SMC Costa Rica to provide increased contract manufacturing solutions, including assembly, injection molding and secondary operations. SMC plans to double the number of workers it has in the Central… […]
  • Sandia Labs seeks partners to make reusable masks
    Sandia National Laboratories has come up with its own version of a reusable respirator for frontline workers. Sandia has filed for patent protection, is testing prototypes, and seeking NIOSH approval and potential manufacturing partners for its elastomeric half-mask N95 respirator. It’s the latest entry to a small but growing category of reusable masks designed to… […]
  • Evco Plastics adds Ga. plant for medtech production
    Evco Plastics (DeForest, Wis.) announced today that it recently purchased a new facility for white room and liquid silicone rubber molding near Calhoun, Ga. The CAL 2 facility has room for 20 injection molding machines of up to 500 tons, and there will be a separate room for new LSR machines. Other features of CAL… […]
  • ABC debuts drama about evil medtech company
    ABC-TV will this week begin airing “Rebel,” an Erin Brockovich-inspired drama in which the main character investigates a fictional medtech company. Stonemore Medical manufactures heart valves that cause autoimmune problems in 3,000 patients, according to ABC. Rebel stars Katey Sagal as Annie “Rebel” Bello, Tamala Jones as Rebel’s ex-sister-in-law Lana, John Corbett as Grady Bello… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS